Thyrocare Technologies Ltd. Earnings/Conference Calls

Thyrocare Technologies Ltd. earnings concalls and investor presentations

Load latest

Thyrocare Technologies Ltd.

20 May 2019

892.50

1.64%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Annual Results of our company for the year ended 31-03-2019. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

11 Feb 2019

892.50

1.64%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding a copy of Presentation on Quarterly Results of our company for the quarter / nine months ended 31-12-2018. Please note that this is only uploaded in our website, and is not being distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

15 Nov 2018

892.50

1.64%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Monday, November 12, 2018 at 02.30 P.M. local time, to discuss the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2018....

pdf

Thyrocare Technologies Ltd.

05 Nov 2018

892.50

1.64%

Investor Presentation

Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2018. Please note that this is only uploaded in our website, and is not being distributed or advertised in newspapers or otherwise publicised.

pdf

Thyrocare Technologies Ltd.

18 Aug 2018

892.50

1.64%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Tuesday, August 14, 2018 at 11.00 A.M. local time, to discuss the Company's Unaudited financial results (Stand-alone and Consolidated) for Quarter ended June 30, 2018. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, GM-Finance and Mr. Vatsal Goyal,...

pdf

Thyrocare Technologies Ltd.

13 Aug 2018

892.50

1.64%

Investor Presentation

Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are forwarding copy of Presentation on Quarterly Results of our company for the quarter ended 30-06-2018. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicized.

pdf

Thyrocare Technologies Ltd.

17 Jul 2018

892.50

1.64%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Sudarshan Padmanabhan, Research Analyst-Investment of Sundaram Asset Management Company Limited, would be having a meeting with our Chairman & Managing Director, Dr. A. Velumani, at our office by 12.00 Noon on Wednesday, July 18, 2018....

pdf

Thyrocare Technologies Ltd.

07 Jun 2018

892.50

1.64%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Ashwin Reddy of Samatva Investments, would be having a meeting with our General Manger-Finance, Mr. Sachin Salvi, at our office by 11.00 A.M. on Friday, June 8, 2018. There could be one or more representatives, and there could be last minute change in timings....

pdf

Thyrocare Technologies Ltd.

23 May 2018

892.50

1.64%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Ms. Roopa Raman of International Finance Corporation (IFC), would be having a meeting with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. today (Wednesday, 23rd May 2018)....

pdf

Thyrocare Technologies Ltd.

09 May 2018

892.50

1.64%

Earnings Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Thursday, May 03, 2018 at 3.00 P.M. local time, to discuss the Company's Audited financial results (Stand-alone and Consolidated) for Quarter/ Year ended March 31, 2018. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO and Mr. Sachin Salvi, GM-Finance and Mr. Vatsal...

pdf